Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03652948 · ClinicalTrials.gov registry record · Phase 2
Meru Health Ascend Mobile Intervention for Depression in Middle Aged and Older Adults
A Phase 2 study, sponsored by Palo Alto Veterans Institute for Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT03652948: Completed Phase 2 study, sponsored by Palo Alto Veterans Institute for Research.
NCT03652948 is a Phase 2 study that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 70 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03652948, a Phase 2 study, has completed, sponsored by Palo Alto Veterans Institute for Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
Using technology to deliver depression interventions is one way could alleviate the public health burden of depression. The study is testing a mobile app intervention program for depression that uses cognitive behavioral skills and mindfulness. This study seeks to obtain feedback on the intervention and refine the intervention and then test the intervention in a larger study. The mobile app intervention called the Meru Health Ascend program consists of the app and therapist support via messaging within the app.
Primary Outcome
The Patient Health Questionnaire 9-item (PHQ-9) is a measure that assesses 9 depressive symptoms with scores ranging from 0 to 27. Higher scores indicate more severe depressive symptomatology.
Interventions
- BEHAVIORAL Meru Health Ascend Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2021-01-15 |
| Phase | Phase 2 |
What the finished NCT03652948 record still lists
NCT03652948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (47% lower).
The record links to 0 conditions, and to 1 intervention - of which Meru Health Ascend Program is the first listed.
NCT03652948 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03652948 about?
NCT03652948 is a clinical study titled "Meru Health Ascend Mobile Intervention for Depression in Middle Aged and Older Adults". Using technology to deliver depression interventions is one way could alleviate the public health burden of depression. The study is testing a mobile app intervention program for depression that uses cognitive behavioral skills and mindfulness. This study seeks to obtain feedback on the intervention...
What is the current status of trial NCT03652948?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2018-07-12. Estimated completion is 2021-01-15.
What interventions are being tested in trial NCT03652948?
The interventions under investigation include: Meru Health Ascend Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03652948?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03652948's enrollment target sits among peer trials
70 937th of 2000 higher than 1,036 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI